Olink

Olink®
Part of Thermo Fisher Scientific

Filters

PublicationDisease areaApplication areaSample typeProducts

Kidney Medicine, 2022
Plasma Kidney Injury Molecule-1 in Systemic Lupus Erythematosus: Discordance Between ELISA and Proximity Extension Assay

Schmidt I., Colona M., Srivastava A. et al.

Olink Target 96Immunological & Inflammatory DiseasesTechnical EvaluationPlasma

Scandinavian Journal of Immunology, 2022
The Karolinska KI/K COVID‐19 immune atlas: An open resource for immunological research and educational purposes

Ljunggren H., Heggernes Ask E., Cornillet M. et al.

Olink Target 96Infectious DiseasesPathophysiologyPatient StratificationPlasma

Nature Communications, 2022
Multicenter phase II trial of Camrelizumab combined with Apatinib and Eribulin in heavily pretreated patients with advanced triple-negative breast cancer

Liu J., Wang Y., Tian Z. et al.

Olink Target 96OncologyImmunotherapyPatient StratificationPlasma

Journal of the American College of Cardiology, 2022
Precision Phenotyping of Dilated Cardiomyopathy Using Multidimensional Data

Tayal U., Verdonschot J., Hazebroek M. et al.

Olink Target 96CVDPatient StratificationSerum

Annals of Oncology, 2022
Impact of acetaminophen on the efficacy of immunotherapy in cancer patients

Bessede A., Marabelle A., Guégan J. et al.

OncologyImmunotherapyPatient Stratification

Multiple Sclerosis and Related Disorders, 2022
Biomarker panel increases accuracy for identification of an MS relapse beyond sNfL

Gawde S., Agasing A., Bhatt N. et al.

Olink Target 96NeurologyPatient StratificationSerum

Atherosclerosis, 2022
Socioeconomic disparity in cardiovascular disease: Possible biological pathways based on a proteomic approach

Shafi B., Bøttcher M., Ejupi A. et al.

Olink Target 96CVDPathophysiology

Molecular Psychiatry, 2022
Elevated endogenous GDNF induces altered dopamine signalling in mice and correlates with clinical severity in schizophrenia

Mätlik K., Garton D., Montaño-Rodríguez A. et al.

Olink Target 96NeurologyPathophysiologyCSF

Annals of the Rheumatic Diseases, 2022
Mechanism of action of baricitinib and identification of biomarkers and key immune pathways in patients with active systemic lupus erythematosus

Dörner T., Tanaka Y., Dow E. et al.

Olink Target 96Immunological & Inflammatory DiseasesPathophysiologySerum

Osteoporosis International, 2022
Effects of denosumab treatment on the expression of receptor activator of nuclear kappa-B ligand (RANKL) and TNF-receptor TNFRSF9 after total hip arthroplasty—results from a randomized placebo-controlled clinical trial

Sköld C., Kultima K., Freyhult E. et al.

Olink Target 96Other Diseases & SyndromesPathophysiologySerum

Thorax, 2022
Relationship between impaired BMP signalling and clinical risk factors at early-stage vascular injury in the preterm infant

Heydarian M., Oak P., Zhang X. et al.

Olink Target 96Respiratory DiseasesPathophysiologyPlasma

PLOS ONE, 2022
Genetically regulated gene expression and proteins revealed discordant effects

Pott J., Garcia T., Hauck S. et al.

Olink Target 96CVDPathophysiologyTechnical EvaluationPlasma

PROTEOMICS, 2022
Stability and reproducibility of proteomic profiles in epidemiological studies: comparing the Olink and SOMAscan platforms

Haslam D., Li J., Dillon S. et al.

Olink Target 96Technical StudiesTechnical EvaluationPlasma

eBioMedicine, 2022
The relationship between disease activity and UDCA response criteria in primary biliary cholangitis: A cohort study

Jones D., Wetten A., Barron-Millar B. et al.

Olink Target 96HepatologyPatient StratificationSerum

European Journal of Heart Failure, 2022
Distinct pathophysiological pathways in women and men with heart failure

Ravera A., Santema B., de Boer R. et al.

Olink Target 96CVDPathophysiologyPlasma

Clinical Kidney Journal, 2022
Kidney oxygenation, perfusion and blood flow in people with and without type 1 diabetes

Laursen J., Søndergaard-Heinrich N., Haddock B. et al.

Olink Target 96Metabolic DiseasesNephrologyPathophysiologyPlasma

Scientific Reports, 2022
Inflammation and remodeling pathways and risk of cardiovascular events in patients with ischemic heart failure and reduced ejection fraction

Girerd N., Cleland J., Anker S. et al.

Olink Target 96CVDPathophysiologyPatient StratificationPlasma

Pediatric Research, 2022
Validation of disease-specific biomarkers for the early detection of bronchopulmonary dysplasia

Kindt A., Förster K., Cochius-den Otter S. et al.

Olink Target 96Respiratory DiseasesPatient StratificationPlasma

Scientific Reports, 2022
Corticotropin releasing hormone as an identifier of bronchiolitis obliterans syndrome

Niroomand A., Ghaidan H., Hallgren O. et al.

Olink Target 96Respiratory DiseasesPatient StratificationPlasma

eBioMedicine, 2022
Higher levels of Bifidobacteria and tumor necrosis factor in children with drug-resistant epilepsy are associated with anti-seizure response to the ketogenic diet

Dahlin M., Singleton S., David J. et al.

Olink Target 96NeurologyPathophysiologySerum

1945 publications